This job has expired

You will need to login before you can apply for a job.

Director Health Economics and Outcomes Research

CSL Behring
King of Prussia, Pennsylvania
Start date
Nov 17, 2023

View more

Job Details

Job Description


The Director of Global Health Economics and Outcomes Research (HEOR) for the Cardiovascular & Metabolism (CVM) Therapeutic Area (TA) is responsible for the development and execution of Patient Access and Economic Value strategies and tactics across the TA.

Lead the development of the global value proposition for the CVM pre-launch and pipeline products.  Develop and lead the health economic value creation plans, and real-world evidence strategies and activities. This role will lead global cross-functional activities in collaboration with clinical development, epidemiology, pricing, marketing, medical, policy/advocacy, and collaborate closely with regional/local HEOR and access leads.

This role will influence the clinical development program to ensure that the patient perspective as well as the payer, and health economic requirements are addressed, and relevant outcomes parameter are included in clinical trial programs.

The Director of Global HEOR will ensure development and timely roll-out of the necessary evidence and value tools including, but not limited to, the Global Value Story, and associated messages, the Global Value Dossier, different types of economic models. In alignment with the global pricing and brand strategy, support optimal differentiation, and value maximization.

Having a pivotal role in designing, substantiating, and executing innovative value-based contracting concepts, including roll-out to and training of the regional/local teams.  Initiate and lead market research projects as well as advisory boards and drive internal and external value communication publications.

This role requires monitoring of HTA guidelines, competitors value communication and reimbursement requirements in key markets to ensure state-of-the-art value substantiation and evidence generation.

This position provides HEOR leadership in Evidence and Access Strategy Teams (EAST) and serve as the HEOR expert within their TA in both internal and external meetings including with government agencies, policy makers, customer, patient representatives and payers, as appropriate. 


Bachelor’s degree in business, health policy, health economics, life sciences or healthcare discipline, MBA preferred.


  • 10+ years of pharmaceutical industry experience including significant HEOR at local, regional and / or global levels.  
  • Demonstrated understanding of product value creation, product differentiation, reimbursement pathways in key countries and knowledge of relevant legal, compliance and regulatory requirements.
  • In-depth understanding of cost-effectiveness, budget impact assessments and HTA requirements in US and key European markets. Proven success in preparation and roll-out of global or local Value Dossiers and RWE generation.
  • Working knowledge of epidemiology and biostatistics is a plus.

About Us

Our Benefits

We encourage you to make your well-being a priority. It’s important and so are you. Learn more about how we care at CSL.

About CSL Behring

CSL Behring is a global leader in developing and delivering high-quality medicines that treat people with rare and serious diseases. Our treatments offer promise for people in more than 100 countries living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. Learn more about CSL Behring.

We want CSL to reflect the world around us

As a global organisation with employees in 35+ countries, CSL embraces diversity, equity and inclusion. Learn more about Diversity, Equity & Inclusion at CSL.

Do work that matters at CSL Behring!


As the third largest global biotechnology company with employees in more than 35 countries, CSL Behring is focused on serving patients with serious and rare diseases, including coagulation disorders, primary immune deficiencies, hereditary angioedema, respiratory disease and neurological disorders. We collaborate with patient and biomedical communities to improve access to therapies, advance scientific knowledge and support future medical research. 

CSL Behring's dynamic environment fosters innovation and attracts the best and brightest who share a commitment to helping save lives. People here are free to live their Promising FUTURES where they can fulfill their individual career aspirations and realize their potential. 

CSL Behring is committed to diversity and inclusion, both of which underpin our Values of patient focus, innovation, collaboration, integrity and superior performance. We believe that by harnessing and honoring the unique capabilities, experiences and perspectives of our people, we are better able to serve our patients.

CSL Behring operates one of the world's largest plasma collection networks, CSL Plasma. The parent company, CSL Limited, headquartered in Melbourne, Australia, employs more than 27,000 people, and provides its life-saving medicines in more than 70 countries. 
For more information visit Help us deliver on our promise to save lives and protect the health of people around the world. Promising FUTURES start at CSL Behring!

Stock Symbol: CSL

Stock Exchange: Australian Securities Exchange

Company info
1020 First Avenue
King of Prussia
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert